Company Overview and News

 
Can Permian Save SM Energy?

2018-04-06 seekingalpha
While SM Energy experienced overall production decline in 2017, its Permian operation is seeing a massive increase in production.
Upvote Downvote

1
The Eastern Company's (EML) CEO August Vlak on Q4 2017 Results - Earnings Call Transcript

2018-03-16 seekingalpha
Good day, everyone, and welcome to The Eastern Company’s Fourth Quarter and Fiscal Year 2017 Earnings Conference Call. Today’s call is being recorded. [Operator Instructions]
Upvote Downvote

 
EML / Eastern Company null (Annual Report)

2018-03-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Upvote Downvote

 
EML / Eastern Company NOTICE & ACCESS

2018-03-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

 
EML / Eastern Company null

2018-03-15 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Upvote Downvote

 
BlueLinx Holdings Case Study - How We Nailed Attractive Entry Point In Shares Of This Building Supply Company

2018-03-14 valuewalk
Bluelinx Holdings Inc. (NYSE:BXC) is a leading distributor of building and industrial products in the US. We started tracking the company in late 2016 as an asset sale put them ahead of schedule in their restructuring efforts. We disclosed our long position on August 4th, 2016 as we internally calculated an EPS number that was much higher than the company reported in its Q2 financial report:
Upvote Downvote

2
Insiders Are Betting Big On These Stocks, And So Am I

2018-03-12 seekingalpha
Four companies that I've followed for quite some time have insider support and Information Arbitrage going for them.
Upvote Downvote

 
Recent Picks From The Exceptional North Star Microcap Fund

2018-02-16 seekingalpha
North Star Microcap (NSMVX) is a mutual fund focusing on microcap stocks based out of Chicago. The fund has a long term record of outperforming its benchmarks, and has done so with one of the smaller average market capitalizations in the mutual fund industry. I follow their picks on an approximately quarterly basis for a few reasons. The biggest reason is that their performance has been excellent. While microcap stocks outperform larger equities as a general rule, the academic explanation is that is due to increased risk, or volatility.
Upvote Downvote

 
EML / Eastern Company / Minerva Advisors LLC - EASTERN CO 13G A3 MINERVA (Passive Investment)

2018-02-13 sec.gov
sc13g UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* The Eastern Company (Name of Issuer) Common Stock, No par value (Title of Class of Securities) 276317104 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed:      [  ]  Rule 13d-1(b)      [X]   Rule 13d-1(c)      [  ]   Ru
Upvote Downvote

 
EML / Eastern Company / Minerva Advisors LLC - EASTERN CO 13G A3 MINERVA (Passive Investment)

2018-02-13 sec.gov
sc13g UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* The Eastern Company (Name of Issuer) Common Stock, No par value (Title of Class of Securities) 276317104 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed:      [  ]  Rule 13d-1(b)      [X]   Rule 13d-1(c)      [  ]   Ru
Upvote Downvote

 
EML / Eastern Company 4TH QTR 2017 FORM 8-K (Current Report)

2018-02-09 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: February 9, 2018 (Date of earliest event reported) The Eastern Company  (Exact name of Registrant as specified in its charter) Connecticut 001-35383 06-0330020 (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation)   Identification No.
Upvote Downvote

 
EML / Eastern Company / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A (Passive Investment)

2018-02-09 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G     Under the Securities Exchange Act of 1934 (Amendment No. 5)*       EASTERN CO/THE (Name of Issuer)   Common Stock (Title of Class of Securities)     276317104                                 (CUSIP Number)                                   December 31, 2017 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is fi
Upvote Downvote

 
EML / Eastern Company / DIMENSIONAL FUND ADVISORS LP - SCHEDULE 13G/A (Passive Investment)

2018-02-09 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G     Under the Securities Exchange Act of 1934 (Amendment No. 5)*       EASTERN CO/THE (Name of Issuer)   Common Stock (Title of Class of Securities)     276317104                                 (CUSIP Number)                                   December 31, 2017 (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is fi
Upvote Downvote

 
These ‘sin stocks’ are increasing sales the most (and CDC boss’s pick doesn’t make the list) - MarketWatch

2018-01-31 marketwatch
Brenda Fitzgerald resigned as director of the Centers for Disease Control and Prevention on Wednesday after Politico reported that she had invested in Japan Tobacco, which sells many popular brands of cigarettes, after she took office.
Upvote Downvote

 
EML / Eastern Company PRESIDENT & CEO AGREEMENT (Current Report)

2018-01-22 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report: January 16, 2018 (Date of earliest event reported) The Eastern Company  (Exact name of Registrant as specified in its charter) Connecticut 0-599 06-0330020 (State or other jurisdiction (Commission File Number) (IRS Employer of incorporation)   Identification No.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 276317104